De novo thrombotic microangiopathy induced by cytomegalovirus infection leading to renal allograft loss.
After kidney transplantation, thrombotic microangiopathy (TMA) can occur de novo or as recurrent disease. Risk factors for de novo posttransplant TMA include ischemia-reperfusion injury, immunosuppressive drugs, viral infections, acute humoral rejection, and complement gene abnormalities. Cytomegalovirus infection as a trigger for posttransplant TMA in kidney transplant recipients has only been reported in 7 cases, all of them between 4 weeks and 8 years after transplantation. We describe a new case of de novo TMA in association with cytomegalovirus infection 25 years after kidney transplantation.
De Keyzer
Kristel
K
Renal Division, Ghent University Hospital, Ghent, Belgium. kristel.dekeyzer@mail.be
Van Laecke
Steven
S
Peeters
Patrick
P
Vanholder
Raymond
R
D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy; D017245:Foscarnet / Q000627:therapeutic use; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000821:virology*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D057049:Thrombotic Microangiopathies / Q000188:drug therapy / Q000821:virology*; D013997:Time Factors
D016756:Immunoglobulins, Intravenous; D017245:Foscarnet; D015774:Ganciclovir